The number of people with susceptibility test result for rifampicin in Lithuania
Lithuania: The number of people with susceptibility test result for rifampicin was 465 in 2021. ▼ Falling
Latest (2021)
465
Change on year
down 3.7%
World rank
82nd
of 155 countries
All-time high
855
in 2017
All-time low
465
in 2021
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Lithuania, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
In 2021, the number of people with susceptibility test result for rifampicin in Lithuania stood at 465. That is the lowest value across all 5 years on record.
The figure is down 3.7% on the previous year and down 45.6% over five years.
That places Lithuania 82nd out of 155 countries with data for 2021, putting it in the middle of the range.
The number of people with susceptibility test result for rifampicin in Lithuania, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 855 | — |
| 2018 | 751 | -12.2% |
| 2019 | 725 | -3.5% |
| 2020 | 483 | -33.4% |
| 2021 | 465 | -3.7% |
Lithuania compared with similar countries
- Lithuania's 465 is above the median for high income countries, which is 142, 3.3× the median. (61 countries reporting)
- Lithuania's 465 is above the median for Europe & Central Asia, which is 229.5, 2.0× the median. (44 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 777 | 725 | 855 | 3 |
| 2020s | 474 | 465 | 483 | 2 |
Countries ranked near Lithuania
More health data for Lithuania
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.4537 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,909 deaths per 1,000 people (2090)
- Number of infants who die before age 1 5 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -4.51 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0199 units per person (2025)
- Population ages 00-04, male, annual growth rate -4.59 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Lithuania?
- The number of people with susceptibility test result for rifampicin in Lithuania was 465 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Lithuania?
- The highest recorded value was 855 in 2017.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Lithuania?
- The lowest recorded value was 465 in 2021.
- How does Lithuania rank for the number of people with susceptibility test result for rifampicin?
- Lithuania ranks 82nd out of 155 countries with data for 2021.
- Where does this Lithuania data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).